DekaBank Deutsche Girozentrale
NVO

DekaBank Deutsche Girozentrale’s Novo Nordisk NVO Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-34,000
Closed -$711K – 1002
2016
Q3 		$711K Buy
+34,000
New +$843K 0.01% 606

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

DekaBank Deutsche Girozentrale's NVO Position: Q4 2016 in Review

DekaBank Deutsche Girozentrale sold out of Novo Nordisk (NVO) in Q4 2016, closing a stake of 34,000 shares — an estimated $711K sold.

DekaBank Deutsche Girozentrale first reported a position in NVO in Q3 2016 and held it in 1 quarter. The position peaked at $711K in Q3 2016. 482 funds tracked by Wall St. Rank hold NVO as of Q4 2016.

  • DekaBank Deutsche Girozentrale reported no remaining Novo Nordisk position as of Q4 2016 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 34,000 Novo Nordisk shares in Q4 2016, an estimated $711K.
  • DekaBank Deutsche Girozentrale first reported a position in Novo Nordisk in Q3 2016 and held it in 1 quarter.
  • DekaBank Deutsche Girozentrale's Novo Nordisk position peaked at $711K in Q3 2016.
  • 482 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2016, filed 20 Jan 2017.